Document is current
Any future updates will be listed below
-
Authors
Yang, Fan
Ni, Beibei
Liang, Xiaoqi
He, Yizhan
Yuan, Chao
Chu, Jiajie
Huang, Yiju
Zhong, Hongyu
Yang, Li
Lu, Jianxi
Xu, Yan
Zhang, Qi
Chen, Wenjie https://orcid.org/0000-0003-1659-4918
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82460130)
National Natural Science Foundation of China (82260110)
National Natural Science Foundation of China (82425010)
National Natural Science Foundation of China (82170674)
Natural Science Foundation of Guangdong Province (2024A1515013044)
China Postdoctoral Science Foundation (2019M653904XB)
Guangzhou Science and Technology Planning Project (202102010310)
Special Fund Project for Science and Technology Innovation Strategy of Guangdong Province (KSYJ2022002)
Kashgar Prefecture Science and Technology Planning Project (KS2023013)
- License Information
-
More Information
Article History
Received: 17 September 2024
Accepted: 24 October 2024
First Online: 7 January 2025
Declarations
:
: All experiments were performed in accordance with the institutional guidelines of the Third Affiliated Hospital of Sun Yat-sen University. The use of animals in this study was approved by the Institutional Animal Care and Use Committee of Sun Yat-sen University and was conducted in accordance with the ARRIVE guidelines 2.0. The approved study is titled “Mechanism of mesenchymal stem cells in relieving ConA-induced liver failure”, with approval granted on December 25, 2023 (Approval number: IACUC-F3-24-0102). The umbilical cords were obtained from healthy mothers at the Third Affiliated Hospital of Sun Yat-sen University with parental consent. The procedure for isolating UC-MSCs was approved by the Research Ethics Committee of the Third Affiliated Hospital of Sun Yat-sen University. The approved study is titled “A Multicenter Randomized Controlled Clinical Study on the Treatment of Hepatitis B-Related Acute-on-Chronic Liver Failure with Allogeneic Human Umbilical Cord Mesenchymal Stem Cells”, with approval granted on December 30, 2020 (Approval number: 2020-14). Informed consent was obtained from all the subjects and/or their legal guardian(s) under the ethical committee of the Third Affiliated Hospital of Sun Yat-sen University.
: All the authors confirm their consent for publication.
: The authors declare that they have no competing financial interests or personal relationships that could have influenced the work reported in this paper.
